Design of a study to evaluate drug therapy of serious ventricular rhythm disturbances after an acute myocardial infarction.
A study was designed to investigate whether long-term use of aprindine can prevent sudden death from primary ventricular fibrillation. Patients with a proven recent myocardial infarction and malignant ventricular arrhythmias occurring late after the acute episode were asked to participate in a 1-yr, double-blind, randomized, placebo-controlled trial to suppress the rhythm disturbances observed on an ambulatory electrocardiogram. Particular care was taken to monitor drug adherence. Arrhythmia detection by ambulatory electrocardiography was used to assess drug efficacy; side-effects establish the maximum tollerated dose for each individual patient. Aprindine was therefore used under optimal circumstances. An interactive computer system served as a data base and provided the investigators and the monitoring committee with all the information required for a proper evaluation of the progress of the study.
D001073:Aprindine / Q000008:administration & dosage / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003201:Computers; D003645:Death, Sudden; D005500:Follow-Up Studies; D006801:Humans; D007192:Indenes / Q000627:therapeutic use*; D007258:Informed Consent; D009203:Myocardial Infarction / Q000150:complications*; D010919:Placebos; D012107:Research Design; D014693:Ventricular Fibrillation / Q000188:drug therapy* / Q000209:etiology
D007192:Indenes; D010919:Placebos; D001073:Aprindine